UGPA_HUMAN - dbPTM
UGPA_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID UGPA_HUMAN
UniProt AC Q16851
Protein Name UTP--glucose-1-phosphate uridylyltransferase
Gene Name UGP2
Organism Homo sapiens (Human).
Sequence Length 508
Subcellular Localization Cytoplasm .
Protein Description Plays a central role as a glucosyl donor in cellular metabolic pathways..
Protein Sequence MSRFVQDLSKAMSQDGASQFQEVIRQELELSVKKELEKILTTASSHEFEHTKKDLDGFRKLFHRFLQEKGPSVDWGKIQRPPEDSIQPYEKIKARGLPDNISSVLNKLVVVKLNGGLGTSMGCKGPKSLIGVRNENTFLDLTVQQIEHLNKTYNTDVPLVLMNSFNTDEDTKKILQKYNHCRVKIYTFNQSRYPRINKESLLPVAKDVSYSGENTEAWYPPGHGDIYASFYNSGLLDTFIGEGKEYIFVSNIDNLGATVDLYILNHLMNPPNGKRCEFVMEVTNKTRADVKGGTLTQYEGKLRLVEIAQVPKAHVDEFKSVSKFKIFNTNNLWISLAAVKRLQEQNAIDMEIIVNAKTLDGGLNVIQLETAVGAAIKSFENSLGINVPRSRFLPVKTTSDLLLVMSNLYSLNAGSLTMSEKREFPTVPLVKLGSSFTKVQDYLRRFESIPDMLELDHLTVSGDVTFGKNVSLKGTVIIIANHGDRIDIPPGAVLENKIVSGNLRILDH
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
2 (in isoform 2)Phosphorylation-34.1325849741
2Phosphorylation------MSRFVQDLS
------CCHHHHHHH
34.1320068231
2 (in isoform 2)Acetylation-34.1321406692
3Methylation-----MSRFVQDLSK
-----CCHHHHHHHH
34.16115386709
9PhosphorylationSRFVQDLSKAMSQDG
CHHHHHHHHHHCCCC
27.0228258704
10UbiquitinationRFVQDLSKAMSQDGA
HHHHHHHHHHCCCCH
56.24-
12SulfoxidationVQDLSKAMSQDGASQ
HHHHHHHHCCCCHHH
4.2030846556
13PhosphorylationQDLSKAMSQDGASQF
HHHHHHHCCCCHHHH
29.9426846344
18PhosphorylationAMSQDGASQFQEVIR
HHCCCCHHHHHHHHH
36.7429396449
33AcetylationQELELSVKKELEKIL
HHHHHHHHHHHHHHH
36.8325953088
332-HydroxyisobutyrylationQELELSVKKELEKIL
HHHHHHHHHHHHHHH
36.83-
33UbiquitinationQELELSVKKELEKIL
HHHHHHHHHHHHHHH
36.83-
41PhosphorylationKELEKILTTASSHEF
HHHHHHHHHHCCCCC
24.6423312004
42PhosphorylationELEKILTTASSHEFE
HHHHHHHHHCCCCCC
22.5423312004
44PhosphorylationEKILTTASSHEFEHT
HHHHHHHCCCCCCCC
30.0924275569
45PhosphorylationKILTTASSHEFEHTK
HHHHHHCCCCCCCCC
25.2726437602
51PhosphorylationSSHEFEHTKKDLDGF
CCCCCCCCCCCHHHH
32.3723312004
522-HydroxyisobutyrylationSHEFEHTKKDLDGFR
CCCCCCCCCCHHHHH
46.31-
52UbiquitinationSHEFEHTKKDLDGFR
CCCCCCCCCCHHHHH
46.31-
69UbiquitinationFHRFLQEKGPSVDWG
HHHHHHHHCCCCCCC
64.26-
692-HydroxyisobutyrylationFHRFLQEKGPSVDWG
HHHHHHHHCCCCCCC
64.26-
69MalonylationFHRFLQEKGPSVDWG
HHHHHHHHCCCCCCC
64.2626320211
69AcetylationFHRFLQEKGPSVDWG
HHHHHHHHCCCCCCC
64.2623954790
69SuccinylationFHRFLQEKGPSVDWG
HHHHHHHHCCCCCCC
64.2623954790
72PhosphorylationFLQEKGPSVDWGKIQ
HHHHHCCCCCCCCCC
41.1821406692
77UbiquitinationGPSVDWGKIQRPPED
CCCCCCCCCCCCCCC
31.26-
772-HydroxyisobutyrylationGPSVDWGKIQRPPED
CCCCCCCCCCCCCCC
31.26-
77AcetylationGPSVDWGKIQRPPED
CCCCCCCCCCCCCCC
31.2626051181
85PhosphorylationIQRPPEDSIQPYEKI
CCCCCCCCCCCHHHH
22.8224275569
89PhosphorylationPEDSIQPYEKIKARG
CCCCCCCHHHHHHCC
17.30-
91AcetylationDSIQPYEKIKARGLP
CCCCCHHHHHHCCCC
43.6023236377
91MalonylationDSIQPYEKIKARGLP
CCCCCHHHHHHCCCC
43.6026320211
91UbiquitinationDSIQPYEKIKARGLP
CCCCCHHHHHHCCCC
43.60-
92 (in isoform 2)Phosphorylation-2.5624719451
102PhosphorylationRGLPDNISSVLNKLV
CCCCCCHHHHHHHEE
22.2025850435
103PhosphorylationGLPDNISSVLNKLVV
CCCCCHHHHHHHEEE
27.1628258704
109 (in isoform 2)Phosphorylation-5.0624719451
119PhosphorylationKLNGGLGTSMGCKGP
EECCCCCCCCCCCCC
22.1529396449
120PhosphorylationLNGGLGTSMGCKGPK
ECCCCCCCCCCCCCH
16.0429396449
124AcetylationLGTSMGCKGPKSLIG
CCCCCCCCCCHHHEE
72.9524885337
137PhosphorylationIGVRNENTFLDLTVQ
EEECCCCCEEEEEHH
21.2827174698
142PhosphorylationENTFLDLTVQQIEHL
CCCEEEEEHHHHHHH
18.8827174698
172AcetylationFNTDEDTKKILQKYN
CCCCHHHHHHHHHHC
50.57155719
177UbiquitinationDTKKILQKYNHCRVK
HHHHHHHHHCCCEEE
44.57-
1772-HydroxyisobutyrylationDTKKILQKYNHCRVK
HHHHHHHHHCCCEEE
44.57-
177AcetylationDTKKILQKYNHCRVK
HHHHHHHHHCCCEEE
44.5726051181
1842-HydroxyisobutyrylationKYNHCRVKIYTFNQS
HHCCCEEEEEEECCC
15.62-
184AcetylationKYNHCRVKIYTFNQS
HHCCCEEEEEEECCC
15.6226051181
186PhosphorylationNHCRVKIYTFNQSRY
CCCEEEEEEECCCCC
10.2821253578
198UbiquitinationSRYPRINKESLLPVA
CCCCCCCHHHCCCCC
46.43-
198AcetylationSRYPRINKESLLPVA
CCCCCCCHHHCCCCC
46.4325038526
280 (in isoform 2)Ubiquitination-4.1021890473
2912-HydroxyisobutyrylationNKTRADVKGGTLTQY
CCCCCCCCCCEEEEE
52.77-
291UbiquitinationNKTRADVKGGTLTQY
CCCCCCCCCCEEEEE
52.772190698
291MalonylationNKTRADVKGGTLTQY
CCCCCCCCCCEEEEE
52.7726320211
291AcetylationNKTRADVKGGTLTQY
CCCCCCCCCCEEEEE
52.7726051181
291 (in isoform 1)Ubiquitination-52.7721890473
294PhosphorylationRADVKGGTLTQYEGK
CCCCCCCEEEEEECE
34.9921406692
296PhosphorylationDVKGGTLTQYEGKLR
CCCCCEEEEEECEEE
29.0128152594
298PhosphorylationKGGTLTQYEGKLRLV
CCCEEEEEECEEEEE
22.7828152594
301UbiquitinationTLTQYEGKLRLVEIA
EEEEEECEEEEEEEE
20.63-
312UbiquitinationVEIAQVPKAHVDEFK
EEEECCCHHHHHHCC
52.87-
3122-HydroxyisobutyrylationVEIAQVPKAHVDEFK
EEEECCCHHHHHHCC
52.87-
312AcetylationVEIAQVPKAHVDEFK
EEEECCCHHHHHHCC
52.8726051181
319AcetylationKAHVDEFKSVSKFKI
HHHHHHCCCCCEEEE
48.1523236377
319UbiquitinationKAHVDEFKSVSKFKI
HHHHHHCCCCCEEEE
48.15-
320PhosphorylationAHVDEFKSVSKFKIF
HHHHHCCCCCEEEEE
36.6226437602
329PhosphorylationSKFKIFNTNNLWISL
CEEEEEECCCEEEEH
18.09-
378PhosphorylationAVGAAIKSFENSLGI
HHHHHHHHHHHHCCC
31.51-
397PhosphorylationSRFLPVKTTSDLLLV
HHCCCCCCHHHHHHH
31.5921406692
398PhosphorylationRFLPVKTTSDLLLVM
HCCCCCCHHHHHHHH
17.9621406692
399PhosphorylationFLPVKTTSDLLLVMS
CCCCCCHHHHHHHHH
31.3421406692
406PhosphorylationSDLLLVMSNLYSLNA
HHHHHHHHHCCCCCC
19.0621406692
409PhosphorylationLLVMSNLYSLNAGSL
HHHHHHCCCCCCCCC
18.5021406692
410PhosphorylationLVMSNLYSLNAGSLT
HHHHHCCCCCCCCCC
20.5021406692
415PhosphorylationLYSLNAGSLTMSEKR
CCCCCCCCCCCCCCC
20.4621406692
417PhosphorylationSLNAGSLTMSEKREF
CCCCCCCCCCCCCCC
21.9821406692
419PhosphorylationNAGSLTMSEKREFPT
CCCCCCCCCCCCCCC
34.4321406692
421UbiquitinationGSLTMSEKREFPTVP
CCCCCCCCCCCCCCC
50.34-
423 (in isoform 2)Phosphorylation-68.0224719451
424 (in isoform 2)Phosphorylation-7.7424719451
426PhosphorylationSEKREFPTVPLVKLG
CCCCCCCCCCEEECC
39.8227362937
427 (in isoform 2)Acetylation-3.34-
434PhosphorylationVPLVKLGSSFTKVQD
CCEEECCCCCHHHHH
32.4919764811
435PhosphorylationPLVKLGSSFTKVQDY
CEEECCCCCHHHHHH
34.8327362937
437PhosphorylationVKLGSSFTKVQDYLR
EECCCCCHHHHHHHH
32.0527362937
437 (in isoform 2)Phosphorylation-32.0524719451
438MalonylationKLGSSFTKVQDYLRR
ECCCCCHHHHHHHHH
35.5726320211
438AcetylationKLGSSFTKVQDYLRR
ECCCCCHHHHHHHHH
35.5719608861
442PhosphorylationSFTKVQDYLRRFESI
CCHHHHHHHHHHHCC
5.7526852163
448PhosphorylationDYLRRFESIPDMLEL
HHHHHHHCCCCHHCC
36.3928192239
459PhosphorylationMLELDHLTVSGDVTF
HHCCCEEEEECCEEE
14.8121406692
461PhosphorylationELDHLTVSGDVTFGK
CCCEEEEECCEEECC
24.848612650
465PhosphorylationLTVSGDVTFGKNVSL
EEEECCEEECCCCEE
31.2621406692
471PhosphorylationVTFGKNVSLKGTVII
EEECCCCEECCEEEE
33.4821406692
475PhosphorylationKNVSLKGTVIIIANH
CCCEECCEEEEEECC
13.6222210691
500PhosphorylationVLENKIVSGNLRILD
EECCEEEECCCEECC
25.9922210691

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources

Oops, there are no upstream regulatory protein records of UGPA_HUMAN !!

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference

Oops, there are no descriptions of PTM sites of UGPA_HUMAN !!

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of UGPA_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions
ARI2_HUMANARIH2physical
16189514
UGPA_HUMANUGP2physical
16189514
MRO2B_HUMANMROH2Bphysical
22939629
UGPA_HUMANUGP2physical
21988832
CUL1_HUMANCUL1physical
22863883
SYFB_HUMANFARSBphysical
22863883
PUR2_HUMANGARTphysical
22863883
HIRP3_HUMANHIRIP3physical
22863883
HS105_HUMANHSPH1physical
22863883
ILK_HUMANILKphysical
22863883
NUDC_HUMANNUDCphysical
22863883
NUSAP_HUMANNUSAP1physical
22863883
PACN2_HUMANPACSIN2physical
22863883
PAPOA_HUMANPAPOLAphysical
22863883
PARVA_HUMANPARVAphysical
22863883
PLOD2_HUMANPLOD2physical
22863883
PPM1G_HUMANPPM1Gphysical
22863883
2A5G_HUMANPPP2R5Cphysical
22863883
PUF60_HUMANPUF60physical
22863883
RANB3_HUMANRANBP3physical
22863883
SET_HUMANSETphysical
22863883
SYTC_HUMANTARSphysical
22863883
RO60_HUMANTROVE2physical
22863883
VASN_HUMANVASNphysical
22863883
ZYX_HUMANZYXphysical
22863883
UGPA_HUMANUGP2physical
25416956
ARI2_HUMANARIH2physical
25416956
GLRX3_HUMANGLRX3physical
25416956
A16A1_HUMANALDH16A1physical
26344197
GLPK2_HUMANGK2physical
26344197
CH10_HUMANHSPE1physical
26344197
KHK_HUMANKHKphysical
26344197

Drug and Disease Associations
Kegg Disease
There are no disease associations of PTM sites.
OMIM Disease
There are no disease associations of PTM sites.
Kegg Drug
There are no disease associations of PTM sites.
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of UGPA_HUMAN

loading...

Related Literatures of Post-Translational Modification
Acetylation
ReferencePubMed
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions.";
Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.;
Science 325:834-840(2009).
Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-438, AND MASS SPECTROMETRY.

TOP